[Current status and future prospects for breast cancer therapy].
Department of Breast and Thyroid Surgery, Kawasaki Medical School.
Hiroshi
H
Sonoo
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001940:Breast / Q000601:surgery; D001943:Breast Neoplasms / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D015195:Drug Design; D004724:Endoscopy; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D019060:Minimally Invasive Surgical Procedures; D019651:Plastic Surgery Procedures; D021701:Sentinel Lymph Node Biopsy; D013629:Tamoxifen / Q000627:therapeutic use; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D000068878:Trastuzumab